As the battle for the White House is heading for a photo finish, Indian pharma industry veterans point out that the election outcome is unlikely to have any significant impact on the local pharmaceutical players.
The prime reason is while the US, just like other countries, is trying to lessen dependence on imports for essential drugs, the Indian industry feels they are likely to take a balanced approach when it comes to sourcing.
Veterans like Cadila Healthcare Chairman Pankaj Patel and Dr Reddy’s Laboratories Chairman Satish Reddy said it was too early to comment.
According to Uday Bhaskar, director general of the Pharmaceutical